Dino Di Carlo is a professor of Bioengineering at UCLA, serial entrepreneur and inventor. He serves in academic leadership roles as the Vice Chair of the bioengineering department and Deputy Director of a National Science Foundation Engineering Research Center. Dr. Di Carlo is also an expert in intellectual property prosecution and litigation. He is an inventor on >50 issued patents in the U.S. and across the world and has served as an expert witness in litigation and IPRs. He also has served in business leadership roles. He co-founded seven startup companies in life science research tools, diagnostics, medical device, and pharmaceutical industries over the last 10 years and continues to serve on the board of directors of many of these companies. As an example, he is a co-founder and director at Cytovale, a 50+ person company commercializing a sepsis diagnostic test for rapid triage in the emergency department. He has also served as a Scientific Advisor to several life sciences companies, including Cue Health (NASDAQ:HLTH) and Omega Biosciences, which was acquired by Becton Dickinson in 2017.